VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 200 filers reported holding VAXCYTE INC in Q2 2023. The put-call ratio across all filers is 4.14 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,264 | +15.0% | 24,790 | +12.7% | 0.06% | +22.9% |
| Q2 2023 | $1,099 | +34.4% | 22,000 | +0.7% | 0.05% | +23.1% |
| Q1 2023 | $818 | -99.9% | 21,837 | -52.0% | 0.04% | -40.9% |
| Q3 2022 | $1,092,000 | +71.2% | 45,505 | +55.2% | 0.07% | +37.5% |
| Q2 2022 | $638,000 | +178.6% | 29,324 | +209.5% | 0.05% | +220.0% |
| Q1 2022 | $229,000 | -24.7% | 9,474 | -25.8% | 0.02% | -60.5% |
| Q4 2021 | $304,000 | +6.3% | 12,766 | +13.1% | 0.04% | 0.0% |
| Q3 2021 | $286,000 | – | 11,286 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 4,168,718 | $100,049,000 | 34.21% |
| Medicxi Ventures Management (Jersey) Ltd | 1,887,478 | $45,299,000 | 18.86% |
| Pivotal bioVenture Partners Investment Advisor LLC | 776,039 | $18,625,000 | 6.81% |
| Kynam Capital Management, LP | 698,638 | $16,767,000 | 3.53% |
| GREAT POINT PARTNERS LLC | 600,000 | $14,400,000 | 3.47% |
| Frazier Life Sciences Management, L.P. | 1,547,405 | $37,138,000 | 2.86% |
| Ghost Tree Capital, LLC | 360,000 | $8,640,000 | 2.42% |
| RA Capital Management | 4,581,203 | $109,949,000 | 2.35% |
| Opaleye Management Inc. | 190,000 | $4,560,000 | 1.88% |
| TPG GP A, LLC | 3,285,504 | $78,852,000 | 1.29% |